Skip to main
PEPG

PepGen Inc (PEPG) Stock Forecast & Price Target

PepGen Inc (PEPG) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

PepGen Inc., a clinical-stage biotechnology firm, operates with a promising Enhanced Delivery Oligonucleotide platform that significantly improves the therapeutic potential of oligonucleotides for severe neuromuscular and neurologic diseases. Analysts highlight a substantial upside potential for PepGen's stock, currently valued around $4 per share, particularly contingent on forthcoming multi-dose data demonstrating a positive risk/benefit profile. Notably, PepGen's 53.7% splicing correction stands out as the highest reported in the DM1 space, which may provide evidence of substantial efficacy, potentially driving improved muscle performance in patients upon repeat dosing.

Bears say

The financial outlook for PepGen Inc is characterized by a $1 decrease in the target price to $8 per share, reflecting challenges in maintaining favorable market valuation despite promising preclinical data. The company's discounted market capitalization appears increasingly anachronistic, particularly in contrast to competitors like Dyne, which are better positioned in terms of regulatory momentum and broad therapeutic applications. Additionally, significant risks loom over the company's operations, as failure to execute commercially or to secure access to capital markets may lead to detrimental delays or even termination of crucial development campaigns.

PepGen Inc (PEPG) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PepGen Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PepGen Inc (PEPG) Forecast

Analysts have given PepGen Inc (PEPG) a Strong Buy based on their latest research and market trends.

According to 4 analysts, PepGen Inc (PEPG) has a Strong Buy consensus rating as of Dec 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $11.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $11.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PepGen Inc (PEPG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.